Clinigen divests global rights to four cancer support therapies to CNX Therapeutics
10 August 2023 Clinigen divests global rights to four cancer support therapies to CNX Therapeutics Clinigen Limited (‘Clinigen’), the global pharmaceutical services company, has completed the divestment of four cancer supportive care products from its …